A painless, micro injection that you can do yourself

A startup under the umbrella of CU Innovation Hub in collaboration with the Chula Faculty of Science has developed an innovative “Detachable and Dissolvable Microneedle” that makes any injections easy and painless for everyone, while also significantly reducing medical wastes.

Those afraid of needles and injections rejoice! Today, getting an injection is no longer scary or painful, because we have a “Detachable and Dissolvable Microneedle”, an innovative microneedle patch that can be implanted, fully detached, and dissolved under your skin! A product from Mineed Technology Co., Ltd., a startup under the umbrella of the Innovation Hub of Chulalongkorn University (CU Innovation Hub) with Prof. Dr. Supason Wanichwecharraung, Department of Chemistry, Faculty of Science, Chulalongkorn University.

“Injection is one form of a typical treatment and prophylaxis that everyone has to deal with, whether it’s vaccination, insulin for diabetics treatment, or even a typical injections to treat facial acnes. In contrast, for people with Trypanophobia, the injection can significantly causes distress, in some cases, severe physical trauma, such as hyperhidrosis patients, who would require 30 injections under each armpit,” Prof. Supason explained about the kickoff ideas of the microneedle patch.

From Problems to the Development of “Detachable and Dissolvable Microneedles”
Microneedles were invented and have been used globally for a while, but they have not been as popular as they should be. Prof. Supason revealed the problem of the previous generation of microneedles “the needles do not dissolve immediately so that patches have to be left on for 2-6 hours. In addition, the levels of moisture on each person’s skin are different, causing the active medication embedded in the needles to absorb at a different rate, not completely dissolve, or do not penetrate the skin of the users.”

“So, we developed this innovation that once the needle patch is in place, the implanted needle can be instantly detached itself into the skin, similar to implanting a splinter into human skin, but in this case, it doesn’t hurt, 100% safe, and a lot quicker than other typical dissolving microneedles.”

Small but full-performance needles
The innovative microneedle contains active medication in a tiny needle of no more than 1 millimeter (1,000 microns). It can quickly dissolve into the skin giving a different sensation than an injection with a typical syringe.

Mr. Chokchai Puangsiri, Director of Business Development, Mineed Technology Co., Ltd., who frequently try the microneedle, described the experience of using the patches, “although it feels like something is touching the skin, it feels far less painful than a typical syringe injection, more like touching the prickly part of the velcro tape. The microneedles can also be self-administered anytime, anywhere without the need for any medical expert anymore.”

In addition to reducing the pain and fear of the syringe, another advantage of using microneedles is that the dosage of medication is much lower. Prof. Dr. Supason gave an example of the COVID-19 vaccination, “there are two types of COVID-19 vaccinations, intramuscular vaccinations, and subcutaneous vaccinations. Subcutaneous injections are better at stimulating the immune while using lower doses than intramuscular injections, but subcutaneous injections are more difficult to inject and, if done frequently, it can cause scarring.”

The innovative soluble microneedles, therefore, make subcutaneous injections a simple matter and eliminate the likelihood of “scarring” from injections with syringes, especially among patients who need regular subcutaneous injections, such as diabetics. Also, dissolving microneedles help significantly reducing the amount of hazardous medical waste like needles and syringes as well.

Microneedles are easy to use. Anyone can give themselves an injection.
Microneedles cater to those who need to have frequent subcutaneous injections so that they do not have to waste their time and money traveling to receive services from healthcare profession. It is also a suitable for those who are afraid of needles or do not dare to give themselves injections.

“In the past, many diabetic patients died because they did not dare to give themselves insulin injections, and therefore, were not properly treated. Therefore, microneedles are the answer for this group of people, because patients can inject themselves easily.”

“Microneedles also help extend drugs’ shelf life, as liquid drugs are solidified to be used in the microneedles, thus their shelf life is extended for up to 1-2 more years.

With various microneedle properties, Mr. Chokchai said the innovation will help healthcare profession in providing telemedicine services without patients having to come to the hospitals for their injections in the future, which is really cost inefficient.

How to use “Detachable and Dissolvable Microneedles”
The Detachable and Dissolvable Microneedle set consists of two components: a microneedle patch, and a moisture patch resembling a wet tissue. The application starts with placing the microneedle patch on the skin where the injection is needed. Use your fingers to press all over the sheet so that the needle containing the drug is embedded under the skin. Place the wet patch over the microneedle patch to dissolve it. Leave it for at least 2 minutes for those needle to be detached and dissolved under the skin. Then, peel off the wet and microneedle patches, and it’s done – both conveniently and quickly.

For people who are worried about allergic reactions, Prof. Dr. Supason explained that “the microneedle is made from hyaluronic acid, which is a polymer that is already exist in any human body, so it surely doesn’t cause any allergic reaction. The needle can be used by anyone, but it also depends on the type of drug or vaccine that is injected. If the user is allergic to the drug or vaccine, it is inevitable that there is a chance for an allergic reaction.”

Group of medicines suitable for microneedles
Microneedles can be used with all types of drugs and vaccines injected subcutaneously, whether they are topical, such as anti-acne, anti keloid scarring medicines, or drugs for bodily systems, such as diabetes, migraine, contraception, etc.

“In our Detachable and Dissolvable Microneedles, we can exactly control the dosage, the depth of the skin layer to be injected, and the time for dissolution rate appropriate to the drugs,” Mr. Chokchai said.

Unsuitable drug types for microneedles are those with high dosage, because of the limited size of patches and needles making them too small for high-dose drugs. The proper dose is 1 mg per square centimeter.

Marketing opportunities for microneedles
Mr. Chokchai mentioned that the current development of microneedles is for two markets: the cosmetics market and the pharmaceutical market.

In the cosmetics market, hospitals and cosmetology clinics, both local and overseas, have ordered and used the microneedles, which have already been registered with FDA in Thailand and Europe, with vitamins and skincare agents. In the future, interested parties with drug formulas can commission the company to develop microneedles.

For the pharmaceutical market, the process is at the Proof of Concept stage, and clinical trials are underway in collaboration with the company’s partners before the products are launched at general pharmacies.

“We tested a variety of medications, such as anti-inflammatories for the skin, acne medicines, and blood-glucose-lowering medicines for diabetics, and it worked well. But to sell them, we need to comply with the Food and Drug Administration’s regulations,” Chokchai said.

The innovative Detachable and Dissolvable microneedles can be developed for many types of medicines, such as herbal patches for mosquito bites. The characteristics and components of the microneedles can also be adjusted to match the performance of any specific medicines, such as the size of the needle, or the duration of dissolution.

Dissolvable microneedles will give people wider access to treatment and preventive medicine because there’s no need to be afraid of needles or pain any longer. Now, needles are only minute matters.

Cloudbae Company and Chula sign MoU for the exchange and cooperation of overseas young talents

On April 21, Cloudbae Company and Chulalongkorn University held the signing ceremony of the MoU on Innovation and Entrepreneurship Cooperation for Overseas Talents at the China-ASEAN Smart City Collaborative Innovation Center. Assoc. Prof. Natcha Thawesaengskulthai, Vice President of Strategic Planning, Innovation and International Cooperation of Chulalongkorn University, and Prof. Worsak Kanok-Nukulcha, Executive Director of Bachelor of Arts and Science in Integrated Innovation (BAScII), attended the signing ceremony and delivered speeches.

The advantage of this MoU is to:

• Jointly research and work on entrepreneurial venture projects in areas of entrepreneurship, smart city solutions, and emerging technologies, including AI, machine learning, and data science.

• Recruit the next generation of employees for consecutive implementation

• Exchange knowledge and talents

Cloudbae Company, started in March 2017, is dedicated to the development and operation of new Smart Cities. The company focuses on Smart City collaborations among Chinese and ASEAN cities and delivers the building, operating and upgrading of smart city collaborations with local governments.

“I-Nanning APP” is the first product launched by CloudBae company in Jan 2018. It is a Municipal Public Service Platform connected with 47 government departments, offering more than 100 services.

By Jan 2021, Cloudbae has accumulated 6 million registered users, out of which more than 600,000 are daily active users. Some highlights of the application are the E-Identification, Once Code Smart Pass, and Real Estate E-Services.

World’s new stream frog found in Myanmar

At about the same time that a new type of green frog was found in the forests of Myanmar, Dr. Panupong Thammachoti a lecturer at the Department of Biology, Faculty of Science, Chulalongkorn University has also found two new types of stream frogs in the Bago region to the north of Yangon, Myanmar.

For Dr. Panupong, a taxonomist and ecologist who has continuously researched reptiles and amphibians in this region, the discovery of these frogs in Myanmar is a reflection of the biodiversity in Southeast Asia which we all should be aware of and work together to ensure its survival.

Genome technology reveals the heredity of a new species of frogs

This discovery is a result of the collaboration between research teams from three countries – Chulalongkorn University’s Faculty of Science, East Yangon University of Myanmar, and Germany’s Senckenberg Forschungs institut und Naturmuseum led by Prof. Dr. Gunther Köhler, an expert in taxonomy and genome technology for reptiles and amphibians.

“We took two years to conduct our research and most of the time was spent collecting specimens both in Thailand and Myanmar after which the frogs were sent for analysis at the Senckenberg laboratory in Germany. The process involved applying our knowledge in physics that’s applied to biology to examine the DNA, analyze the vocal variations of frogs, as well as study the genome, or the entire genetic data of these frogs until we found two of the world’s newest species of frogs.” Dr. Panupong explained the process of the research project on the diversity of stream frogs in Myanmar, and the mountain range in the western and southern part of Thailand which began in 2019.

The study that led to the discovery of the two species of stream frogs has been documented and published in the international journal, Diversity, in August of 2021.

The characteristics of the world’s new stream frogs

Dr. Panupong explained the general characteristics of the stream frog that “their habitat is in the streams of tropical forests like the jungles in the western and southern part of Thailand. The size of each frog is about 3-5 centimeters. Their bodies are brown and appear much like a leaf which is a form of camouflage. These frog species only make mating calls at night. As tadpoles, they live around the streams where the gush of water isn’t very strong and when they are fully grown will move to the side of the stream. They are found mostly in the rainy season which is their mating season.”

The two newly discovered species of stream frogs are the Bago Stream Frog (Limnonectes bagoensis) and the Bamboo Forest Bago Frog (Limnonectes bagoyoma).

“Both types of frogs are similar in that their skin is slippery, they are dark brown or brown mixed with olive green. Their forelegs have four toes without connective tissue while the hind legs have five toes with connective tissues that enable them to swim. The skin on their backs is quite smooth with only a few lumps while the skin on their stomachs is white or cream-colored, very smooth and not lumpy.”

“In terms of differences, the Bago Stream Frog has a black strip from the end of its nose to the side of the ear and its body size is 30-49 centimeters. It is larger than the Bamboo Forest Bago Frog which measures 23-29 centimeters.”

Relationship between frogs and the ecosystem

The discovery of these new species of frogs is a good indicator of the fertility of the forests in Southeast Asia since the habitat of these frogs are natural bodies of water that are clean, clear, and always flowing.

Although there are still some stream frogs remaining, Dr. Panupong reminds us that the numbers are dwindling and if deforestation continues the changes in forest conditions could eventually lead to the frogs’ extinction.

“We hope that the knowledge generated from this research will let people see the importance of forests and refrain from cutting down trees and destroying forests. It is also important to find ways to develop the appropriate form of ecotourism that also leads to the conservation of forests.” Dr. Panupong added.

The future of other species discoveries

Dr. Panupong continues to study and disseminate knowledge on reptiles and amphibians in Thailand. He plans to further his research on stream frogs and frogs in the south of Thailand which have features that are similar to frogs found in Myanmar. Research will also be carried out on other reptiles such as the world’s new skink found on the mountains of Indonesia, the Kukri snake which isn’t poisonous but often likes to eat the eggs of poisonous snakes, and the rattlesnake which is highly poisonous. We often hear news of people being bitten by this type of snake.

Dr. Panupong ended by sharing his opinion that “The discovery of new animal species is an indicator of the fertility of forests in our region.

I believe there are still a large number of reptiles and amphibians waiting for us to discover and study. Research on these animals will enable us to understand the significance of the animal life that coexists with humans in the ecosystem. Some of the reptiles and amphibians can be beneficial in terms of science and technology.

Even if their appearance isn’t as attractive as other animals and some are also poisonous but they are important to the ecosystem, the study and research on natural history and biology which also includes the way of life of these animals will help us humans to be able to sustainably maintain the balance of the ecosystem.”

Chula urges researchers to launch Deep Tech

Chulalongkorn University Technology Center (UTC) urges Deep Tech researchers to push forth deep innovations onto the market, promote business ventures, and be the driving force in the Thai economy.

DeepGI artificial intelligence detection of colorectal cancer, Aqua Innovac needle-free aqua vaccine for farmed fish, ReadMe by eikonnex.ai, an artificial intelligence device that reads texts, images, and videos and transfers them to digital documents.

These are but a few of the 30 outstanding innovations from in-depth research or Deep Tech by Chulalongkorn Universities researchers and their networks supported by Chulalongkorn University Technology Center: UTC.

According to Dr. Pravee Kruachottikul who heads Chulalongkorn University Technology Center (UTC) “Good research not only contributes towards cultivating academic knowledge but can also be of added value when it is put to actual use. UTC is determined to provide a platform to accelerate Deep Tech research works onto the market by creating impactful research that sustainably addresses social and economic questions.”

Deep Tech is in-depth technology that is highly complex and cannot be easily imitated within a short time which proves advantageous in the highly competitive business arenas. Dr. Pravee also added that there are a large number of Deep Tech research in Thailand that have been published and are widely accepted internationally, but unfortunately, haven’t been utilized fully. Moreover, if researchers were to work on their own, they might not be able to add the commercial dimension to their work in a more substantial manner. UTC was therefore established to address this gap.

“Innovations deriving from Deep Tech can be patented, and are therefore able to add social and economic value following Chula’s Innovations for Society concept.”

How does UTC provide support for Deep Tech research?

Currently, UTC concentrates on working with three types of Deep Tech research, namely Artificial Intelligence (AI), Medical Technology (MedTech), and Biotechnology (BioTech). Its work begins with a search for Deep Tech research, after which UTC will work closely with the research team to improve its capacity for commercialization and specific technology readiness by UTC’s qualified specialists as well as its alliance of experts comprising experts in innovation project development, and business planning.

They will help in offering advice at various stages such as business model development, market testing, selection of commercial models, etc. Experts in business laws and patent strategies can offer advice on such matters as the IP landscape or food and drugs registration.

Specialists in specific areas, such as applied AI in medical technology will offer their advice on how to conduct clinical trials, disbursement systems, or strategies for ensuring physician’s adoption of technology, etc. There are also coaches from outside Chulalongkorn University who provide advice on innovation development, some of whom are Chula alumni, business practitioners, and those working on social projects.

Developing Deep Tech for the Innovation Market

Dr. Pravee explained that turning research into a commercialized innovation should not extend over 12 months. The process entails the three major steps:

1. The search for available research
UTC is constantly on the lookout for and welcomes submissions of research and has committees to consider plausible research projects. Once the research has been accepted, another team of experts on innovation development will oversee the project to enhance its business potentials alongside technological development until a primary business model is derived. They are then able to assess the potential of the research in providing solutions for the target market and whether there are interested customers.

2. Product Development and field testing with potential customers or actual product users.
With the derived business plan, the research team can soon develop a model that can then undergo actual market testing with the target group. UTC’s experts or coaches in various dimensions are there to provide advice after which the test results are applied to make changes or improvements as needed so that the product follows the direction set within the determined timeframe.

3. Proceeding with the commercial aspect
Once the desired product has been developed, the next step is to plan how to handle its commercial aspect to derive the highest benefits. UTC’s experts are there to provide such useful information as legal matters, patent application, the transmission of technology/patents from the university, negotiations with business partners, and fundraising for example.

UTC’s Deep Tech Innovations

For almost three years (2019 onward), the UTC has played a part in cultivating more than 36 Deep Tech research projects. At the end of 2021, the UTC Deep Tech Demo Day was organized to showcase outstanding AI and MedTech Innovations from 15 teams that showed the potential to become Thailand’s Deep Tech Startups in the future. The event had online booths displaying more than 30 AI and MedTech innovations and also featured a Business Matching activity with agencies from both the government and private sectors. Internationally renowned experts were invited to share their expertise on matters related to Deep Tech. Some of the innovations presented at the event are as follows:

ReadMe by eikonnex.ai
by researchers from Chulalongkorn University’s Faculty of Engineering — an AI innovation with the ability to read texts in Thai and English along with symbols on documents, images, and videos and transform them into digital documents that can be used in various ways, such as company’s financial documents storage, credit scoring for bank loans, etc.

Aqua Innovac
a needleless vaccine for farmed fish by researchers from the Faculty of Veterinary Science, Chulalongkorn University. An innovation that prevents infection from a bacterium that causes Branchiomycosis or “gill rot disease”, and reduces deaths in fish caused by stress after vaccination with needles.

DeepGI
by a joint research team from the Faculty of Engineering, and the Faculty of Medicine that features AI detection of colorectal cancer that improves diagnosis and reduces the number of examination errors.

How does one join UTC projects?

Not only does UTC lend its support to researchers affiliated with Chulalongkorn University, but it is also open to Deep Tech researchers from elsewhere, especially in the fields of AI, MedTech, and Biotech which are UTC’s main concentrations. Other Deep Tech research works are also welcome.

Dr. Pravee concluded that students who are interested in Deep Tech but do not have any research works can also join the UTC team to undergo practical training.

Early detection saves lives: HPV testing kits Chula’s innovation for women’s health

Chulalongkorn University’s researchers have developed a cervical cancer test kit that uses urine samples. A simple, accurate, and fast method of early detection is guaranteed for its quality by the 2021 Outstanding Inventions Award from the National Research Council of Thailand.

Cervical cancer can be cured if detected in its early stages. Many women are, however, deterred by the rather high cost of the screening procedure, and the pap smear testing method. This leads to late detection that can cause cancer to spread making it harder to treat.

Today, there is a new invention that makes cervical cancer treatment a simpler and pain-free procedure that can be done frequently.

The HPV paper-based DNA sensor testing kits for cervical cancer developed by the Department of Chemistry, Faculty of Science, Chulalongkorn University’s research team comprising Prof. Dr. Orawan Chailapakul, Dr. Prinjaporn Tee-ngam, Sarida Naorungroj, Dr. Somrak Petchcomchai along with Prof. Dr. Tirayut Vilaivan

Dr. Prinjaporn, one of the main researchers on the team discussed how this innovation was conceived, “The government has consistently urged women to get tested for cervical cancer. One of the limitations of the original form of testing which requires taking a sample of cells from the cervix on stirrups invokes fear in many women who would rather avoid the test altogether. For this reason, we have tried to find an easier way that most women would feel more comfortable with. This could help to increase the number of those being tested as well as the frequency of their tests so that if any anomalies are found, then treatment can be immediately provided.”

Getting to know cervical cancer

Cervical cancer is the second most common cancer of women in Thailand after breast cancer with an incidence rate of 10,000 new cases per year affecting women between the ages of 30-60 and claiming as many as 5,000 deaths each year. The Ministry of Public Health recommends that from the age of 25 women should receive regular screening for cervical cancer every five years.

Prof. Dr. Orawan explains that cervical cancer is a sexually transmitted disease, mainly caused by the human papillomavirus (HPV). The use of condoms as protection cannot prevent such transmission, and the HPV vaccine is not yet prevalent or provides 100% protection against cervical cancer.

She also stressed that “Most of those who have been affected are asymptomatic which makes it necessary for us to still be tested regularly since that is a crucial way to prevent us from the disease and death.”

The HPV paper-based DNA sensor testing kits

The cervical cancer testing kits are easier and much faster than the Pap Smear or Pap Tests currently in use. It eliminates the need to insert a tool and hold the vaginal walls open as well as swabbing over the cervix to take cell samples that are sent to the lab for testing.

“HPV paper-based sensor testing is a way to test the DNA of the HPV virus by using PNA (Peptide Nucleic Acid) which is a synthetic substance that imitates our DNA designed to be specific according to the cells being tested which can be specified since HPV comes in many different strains and not all strains cause cervical cancer. When designing the substance, we needed to determine which strains there were when it comes to HPV infection,” said Prof. Dr. Orawan.

The HPV paper-based sensor testing kit is something that a lot of us are already familiar with from the ATK tests we have undergone for COVID-19.

“The urine is mixed in a solution then dropped onto the paper after which we notice the change in color of the solution. Normally the color of the solution is bright red but if the urine is contaminated by the virus the color appears lighter. The brightness of the color varies according to the amount of the virus. We have an additional tool, used with the colorimeter application on smartphones that helps make the color more visible.”

Prof. Dr. Orawan assured us that the HPV paper-based sensor testing kit has been tested and shows a high level of accuracy with a sensitivity of 85%, specificity of 78%, and reproducibility rate of 100%.”

The HPV Testing Kits have not been produced for home use. They are, however, being used in health centers and community hospitals.

“In the urine, there are fewer DNA materials than in tissues, which means we need to have a device that increases the DNA level so that the change of color is more visible and the device is already in use in the clinics and community hospitals.”

How to watch over our health to stay away from cervical cancer

Prof. Dr. Orawan left us with some tips on how to help women stay safe from cervical cancer. “First, women should make sure they always keep their vaginal areas clean. Vaccinations are good but the prevention they offer isn’t a hundred percent. The best way is to have regular cervical cancer checkups for early detection and treatment.”

The research team hopes that this innovation will motivate women to get themselves tested regularly, with a simple and painless process, at an affordable price. Each test kit should not exceed 500 baht.

Prof. Dr. Orawan left us with these words. “We’d like to see women getting cervical cancer tests regularly as advised by the Ministry of Public Health. Therefore, we have tried to make the cost of these kits as low as possible to make them easily accessible. It would be ideal if women can be tested regularly, for example once a month at a health center nearby.”

Nursing facilities or agencies interested in these HPV paper-based DNA sensor testing kits may contact Prof. Dr. Orawan Chailapakul at the Department of Chemistry, Faculty of Science, Chulalongkorn University, email address [email protected] for more information.

Chula and Johns Hopkins Cochlear Center open training programme in aging, hearing, public health

Did you know that loss of hearing increases the risk of dementia by nearly two folds?

Chulalongkorn University and the Johns Hopkins Cochlear Center for Hearing and Public Health have collaborated on a training program in Aging, Hearing and Public Health for Health Care Professionals. The program is catered for healthcare leaders in Asia keen on helping older adults with hearing problems.

The training will begin in May 2022 (online), and selected applicants will be invited to join the onsite workshops during 15-16 August 2022.

Studies show that risk of dementia increases by 1.94 folds with hearing loss, the highest modifiable risk factor for the illness. Fortunately, early detection and treatment of hearing loss may prevent dementia and the World Health Organization recommends early screening for hearing loss from the age of 50.

During the training, participants will be guided on how to screen for hearing loss and design a program to suit specific communities within a country.

The Program in Aging, Hearing and Public Health for Health Care Professionals jointly provided by Johns Hopkins and Chulalongkorn University will provide:

– Opportunities for participants to meet other researchers and potential leaders from across Asia.

– Guidance for a country’s policy.

– Improved clinical skills to help older adult patients.

Be a part of an innovative program that will make a difference.

Register or find out more about the program at: https://mooc.chula.ac.th/courses/269.

For more information about the interactive sessions from the Johns Hopkins Cochlear Center for Hearing and Public Health visit: https://courseplus.jhu.edu/core/index.cfm/go/syl:syl.public.view/coid/14538/.

Full scholarships announced for international applications to study Integrated Innovation

Full Scholarships have been announced for international applicants who wish to pursue the Bachelor of Arts and Science in Integrated Innovation (BAScii), a four-year degree programme offered by the Chulalongkorn School of Integrated Innovation (ScII).

Launched in 2018, the four-year Bachelor programme is one of its kind, with many firsts to its credit. ScII holds the distinction of being the first educational institute in Thailand to achieve ISO 56002 accreditation. The school is also a hub of talented international faculty members who have joined its newly established Global Innovator Faculty Towards Early-Career Development (GIFTED) Faculty Scholars programme. Additionally, all students must spend a semester studying abroad in a top-class international elite institution. A good example is our students currently enrolled in the Exchange StartUp Semester at the Sutardja Center for Entrepreneurship & Technology (SCET), University of California Berkeley, where they have been featured on the SCET website and in a video.

“Students are expected to develop startups before graduating, and as young entrepreneurs, owning a startup may be the most rewarding, exciting, and positive experience of their lives,” Professor Worsak Kanok-Nukulchai, Executive Director, ScII, said. “We want our students to become Technology Innovators, Innovation Entrepreneurs, Social Transformers, and Digital Age Professionals,” Prof Worsak added. The school equips its students with the skills necessary to face a changing world, where technological disruption is upending societies (Read Philosophy & Approach: LINK).

All BAScii students take digital technology and entrepreneurship courses, which will serve as the foundation for startups in four focus areas: health and wellness, smart cities, sustainable development, and applied digital intelligence.

Industry-sponsored scholarships cover the full cost of tuition and fees of 1.768 million baht (approximately USD 55,000) for international students from outside Thailand. Moreover, needy students will receive a monthly stipend to cover the cost of living in Bangkok. ScII has also partnered with several corporate and industrial organizations, which will offer internships and projects to BAScii students.

Applications for admission and scholarships are now open until May 3, 2022. You can apply through the ScII website.

Details of Scholarship Programme: https://scii.chula.ac.th/blog/call-for-scholarship-applications-from-international-students-2022

Contact Admissions: [email protected]

Chula architecture professor receives knight title of the Order of Academic Palms from French Government

Congratulations to Asst. Prof. Dr. Niramon Serisakul, Director of Urban Design and Development Center, Department of Urban and Regional Planning, Faculty of Architecture, who has received the prestigious distinction of Chevalier dans l’Ordre des Palmes académiques (Knight of the Order of Academic Palms), awarded by the Government of the French Republic.

The award was given in recognition of Dr. Niramon’s dedication and work in advancing urban planning and development education, promoting eco-friendly urban and community planning, and facilitating research collaboration between Thailand and France.

The Academic Palms, the oldest non-military French decoration, was established by Napoleon in 1808 to recognize the outstanding contributions of teachers through their teaching and leadership.

“I would like to thank Chulalongkorn University, Department of Regional and Urban Planning, Faculty of Architecture, and the Thai Health Promotion Foundation for giving me the trust and opportunity to jointly drive the Urban Regeneration Project, both professionally and academically”, said Asst. Prof. Dr. Niramon Serisakul, the Director of Urban Design and Development Center (UddC). The Urban Design and Development Center (UddC), established in March 2013 through the collaboration of the Thai Health Promotion Foundation and Chulalongkorn University, was set up to develop, oversee, and conduct research on city regeneration projects.

“I would like to also express my gratitude to the French Embassy in Thailand and the Research Institute for Contemporary Southeast Asia (IRASEC) for recognizing UddC’s work and nominating me for this distinguished award”, added Dr. Niramon.

The works of Asst. Prof. Dr. Niramon and UddC have great influence on the urban planning and development of major cities in several provinces, including:

The Bangkok250 Project (Phase 1 and 2)
Prapokklao Sky Park
Bangkok Green Bridge
Yannawa Riverfront
Kadeejeen-Klongsan Urban Renewal
Development Plan for Ratchadamnoen Klang Road
CU 2040 Master Plan
Observatory (Bangkok and Chiang Mai)
Learning City (Bangkok and Nakhon Sawan)
Study of rehabilitation guidelines for the Sukhumvit-Bang Na area (Bangna)
The GoodWalk Project (Bangkok, Chiang Mai, Phuket and Khon Kaen)
“This great recognition is not due to only my efforts, but also the efforts of many people, including the team and UddC consultants who are all skilled, committed to the public service mindset, and love their profession. Also, to be credited are the people in the Kadeejeen-Khlongsan areas, households, temples, churches, mosques, schools, universities, and district offices that have opened opportunities for cooperation and involvement since 2009.

Moreover, Asst. Prof. Dr. Niramon acknowledges the Association of Siamese Architects under the Royal Patronage, the Art and Architecture Preservation Commission, and the Rockefeller Foundation for supporting UddC’s work and being part of UddC’s success for four consecutive years.

iHub Chula’s new breed of startups to internationalise the Thai economy

Chula’s strategy to push CU Innovation Hub (iHub) to produce quality graduates and a new breed of startups to drive Thailand 4.0 through innovation now pays off with a 16-billion-baht valuation of innovative products.

Currently, innovation is what drives global economic trends, as reflected in national policies of many countries, namely Made in China 2025, Manufacturing USA, Japan’s Society 5.0, South Korea’s I-Korea 4.0, and Malaysia’s Industry 4WRD. Based on its 20-year national strategy, Thailand has laid down Thailand 4.0 development plan that will transform its economy from “efficiency-driven” to “innovation-driven” by 2036.

Innovation development needs “innovators” to bring a positive change to the country and the world. Many countries are working to create such incubators and offer desirable incentives to attract top talent from many countries.

Though Thailand started to promote the Thailand 4.0 policy in 2017, the number of high-quality workers is still limited. Chulalongkorn University, therefore, established the Chulalongkorn University Innovation Hub, or CU Innovation Hub, aka iHub to accelerate the creation of quality graduates to help drive the country to the future.

iHub and its mission to create a new breed of startups

CU Innovation Hub (iHub) was founded in 2017 mainly to promote and support the creation of innovations that will usher the Thai society into a new way of life, learning, and creativity; to produce graduates who will become the leaders of the future via technology and intellectual properties and dare to create a disruptive change in conventional industries, and challenge the traditional mindset in the workplace. “Thailand 4.0 will never reach its 2017 goals of becoming a developed country without quality human resources who will solve the country’s problems with new and sustainable solutions,” said Dr. Santhaya Kittikowit, Chula Vice President for Innovation and New Development, and Director of CU Innovation.

Apart from creating a new breed of startups, Dr. Santhaya said that CU iHub also supports innovation, patents, use of intellectual property, application for society, income generation, and creation of economic value for Thailand. With five areas of concentration: Health/Aging, Education, Bio-Circular Green Food & Agriculture, Sustainable Society, and Deep Tech Supercluster, iHub had 300 startups under its umbrella in 2021 with a market valuation of over 16 billion baht.

Chula announces the “personalised cancer vaccine” project

Chulalongkorn University held a Chula the Impact 7 Seminar on “the Progress of Personalized, Therapeutic Cancer Vaccine: An Innovation of Hope for Thai Society” by the CU Cancer Immunotherapy Excellence Center, Faculty of Medicine, and the King Chulalongkorn Memorial Hospital, Thai Red Cross Society, funded by the Second Century Fund, Chulalongkorn University (C2F).

Assoc. Prof. Virote Sriuranpong, M.D., Ph.D., Head of the Excellence Chulalongkorn Comprehensive Cancer Center, King Chulalongkorn Memorial Hospital said that the Center’s research on cancer immunotherapy focuses on three areas: cellular immunotherapy, personalized therapeutic cancer vaccine, and therapeutic antibody drugs, that can be used in combination or as a standalone treatment.

Trairak Pisitkun, M.D., Head of Center of Excellence in Systems Biology, Faculty of Medicine, Chulalongkorn University said that the Center began to develop personalized, therapeutic cancer vaccines in 2017, and the project is in its Phase I of clinical trials in volunteers starting in January 2021. This is the first trial in Thailand, and Southeast Asia.

Over the past year, the team has tested personalized vaccines on four volunteers with stage-4 cancer: 3 with melanoma, and 1 with renal cancer. Results show that the vaccines are safe, and have mild side effects. After three weeks, a good immune response to specific mutation was found in all four patients.

The team also monitored the pathological response in one patient by assessing the distribution of T cell lymphocytes in cancer biopsies. Before receiving the vaccination, white blood cells were detected mainly around the periphery of the tumor. After vaccination, white blood cells penetrated more into the cancerous tissue. This patient is currently stable after receiving the vaccine and being monitored for 9 months.

Within a span of the next four years, the next phase of the clinical trial is expected. When the vaccine’s efficacy and safety are proven, the team will proceed with the patent. Meanwhile, antibody drugs are being manufactured. Animal testing is expected to commence in 2022. If successful, both the vaccines and antibody drugs can be used in combination for better results, and lower costs for patients.

Meanwhile, a special clean room for the production of more personalized vaccines is under construction to add on to the comprehensive cancer patient care as part of the “Integrated Cancer Research and Treatment Center of King Chulalongkorn Memorial Hospital, Thai Red Cross Society”. Its completion is expected in February 2024.